Cardiologist and Diabetologist crosstalk in the era of cardiovascular outcome trials of novel glucose-lowering drugs

The prevalence of type 2 diabetes continues to increase and cardiovascular (CV) diseases remain the leading cause of death in diabetic patients. Diabetologists and Cardiologists have to work together in order to provide the best management to these patients. After years of disappointing studies show...

Descripción completa

Detalles Bibliográficos
Autores principales: Maranta, Francesco, Cianfanelli, Lorenzo, Regoni, Maria, Cianflone, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205052/
https://www.ncbi.nlm.nih.gov/pubmed/30402533
http://dx.doi.org/10.1016/j.ijcha.2018.10.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205052/
https://www.ncbi.nlm.nih.gov/pubmed/30402533
http://dx.doi.org/10.1016/j.ijcha.2018.10.001

Ejemplares similares